Eton Pharmaceuticals Files 8-K
Ticker: ETON · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1710340
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Eton Pharma filed an 8-K, looks like standard procedure, no big news.
AI Summary
Eton Pharmaceuticals, Inc. filed an 8-K on June 27, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about new events, financial figures, or material agreements, but rather serves as a procedural update.
Why It Matters
This filing indicates a routine update or submission of required documentation by Eton Pharmaceuticals to the SEC, without disclosing new material information.
Risk Assessment
Risk Level: low — The filing is a routine 8-K submission and does not contain any new material information that would immediately impact the company's risk profile.
Key Players & Entities
- Eton Pharmaceuticals, Inc. (company) — Registrant
- June 27, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-38738 (identifier) — Commission File Number
- 37-1858472 (identifier) — I.R.S. Employer Identification Number
- 21925 W. Field Parkway, Suite 235 Deer Park, Illinois 60010-7278 (address) — Principal Executive Offices
- (847) 787-7361 (phone_number) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report "Other Events" and "Financial Statements and Exhibits" as of June 27, 2025.
What is the exact date of the report?
The exact date of the report is June 27, 2025.
In which state was Eton Pharmaceuticals, Inc. incorporated?
Eton Pharmaceuticals, Inc. was incorporated in Delaware.
What is the principal executive office address for Eton Pharmaceuticals, Inc.?
The principal executive office address is 21925 W. Field Parkway, Suite 235, Deer Park, Illinois 60010-7278.
Does this filing disclose any new material events or financial information?
Based on the provided text, this filing appears to be a procedural update and does not explicitly disclose new material events or specific financial figures.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding Eton Pharmaceuticals, Inc. (ETON).